Trademark: 79325766
Word
ENPOLYAB
Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
79325766
Registration Number
7232429
Registration Date
Tuesday, December 5, 2023
Mark Type
4000
Filing Date
Thursday, September 16, 2021
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
BIOTEST AG - Original Registrant

Classifications
5 Pharmaceutical products and medical products, namely blood for medical purposes; medical preparations, namely blood for medical purposes; pharmaceutical proteins and medical protein preparations made from human blood, blood plasma and blood serum, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins, all being pharmaceutical preparations for preventing and treating of immune system related diseases and disorders, neurological diseases and disorders, cancer, infections; pharmaceutical preparations for immunology, neurology, intensive medicine, transplantation medicine, oncology, namely pharmaceutical preparations for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer, and infections; pharmaceutical preparations for preventing and treating viral diseases, diseases of the immune system, autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying or toxin-neutralizing medicines, namely pharmaceutical preparations for treatment of immune-related diseases and disorders and for treatment of allergies and for treatment of infections

Trademark Events
Mar 26, 2024
Final Decision Transaction Processed By Ib
Mar 6, 2024
Final Disposition Notice Sent To Ib
Mar 5, 2024
Final Disposition Processed
Mar 5, 2024
Final Disposition Notice Created, To Be Sent To Ib
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2023
Published For Opposition
Sep 17, 2023
Notification Processed By Ib
Aug 30, 2023
Notification Of Possible Opposition Sent To Ib
Aug 30, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 17, 2023
Approved For Pub - Principal Register
Aug 17, 2023
Examiner's Amendment Entered
Aug 17, 2023
Notification Of Examiners Amendment E-Mailed
Aug 17, 2023
Examiners Amendment E-Mailed
Aug 17, 2023
Examiners Amendment -Written
May 9, 2023
Notification Of Possible Opposition - Processed By Ib
Apr 19, 2023
Notification Of Possible Opposition Sent To Ib
Apr 19, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 31, 2023
Notification Of Final Refusal Emailed
Jan 31, 2023
Final Refusal E-Mailed
Jan 31, 2023
Final Refusal Written
Dec 29, 2022
Teas/Email Correspondence Entered
Dec 29, 2022
Correspondence Received In Law Office
Dec 29, 2022
Teas Response To Office Action Received
Jul 26, 2022
Refusal Processed By Ib
Jul 2, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 2, 2022
Refusal Processed By Mpu
Jun 25, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 24, 2022
Non-Final Action Written
Jun 21, 2022
Assigned To Examiner
Nov 23, 2021
Application Filing Receipt Mailed
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24